EUVIMEDEUVIMED entdecken
Crossref

Chronic Anatabine Administration Attenuates Cardiovascular Activity by Targeting NF-κB/NLRP3/Caspase-1-Dependent Pyroptosis and Oxidative Stress in Paraventricular Nucleus of Hypertensive Rat

Qing Su, Shao-Jun Li, Jun-Yu Zhou, Jin-Bao Yang, Fang Zhao, Guo-Quan Zou, Jia-Xuan Ma, Qi Liu, Yuan-Yuan Feng, Cui-Ling Yang, Ying Li, Hong-Bao Li und 1 weitere

Cardiovascular Toxicology · 2025

DOI: 10.1007/s12012-025-10034-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2025. Verfasst von Qing Su und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an, 710061, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Oxidative Stress, Paraventricular Hypothalamic Nucleus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Province Key Research and Development Program of Shaanxi, Fundamental Research Funds for the Central Universities, Shaan'xi Province Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is characterized by chronic inflammation. Anatabine, a natural alkaloid with anti-inflammatory properties, has demonstrated potential in regulating inflammatory pathways. However, its impact on cardiovascular activity in the context of hypertension remains unclear. The aim of this study was to explore the effects of anatabine on cardiovascular activity in hypertensive rats, with a specific focus on the underlying mechanisms related to inflammation and oxidative stress, particularly the role of NLRP3 inflammasome and pyroptosis in the PVN. Fecal samples were collected from male spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) rats, followed by untargeted metabolomics analysis by liquid chromatography-mass spectrometry (LC-MS). Anatabine (ANT) was identified as enriched in WKY while lacking in SHR and thus was subcutaneously administered via mini-pump (0.014 mg/kg/min) in SHR or WKY rats for 12 weeks. Systolic blood pressure was recorded weekly. In vitro, microglia (HMC3) were divided into control, angiotensin II (Ang II), Ang II + anatabine, and Ang II + anatabine + PapRIV (Pap, NF-κB activator) groups. High blood pressure significantly triggered nucleotide-binding domain, leucine-rich-containing family pyrin domain containing 3 (NLRP3)-dependent inflammasome activation (ASC, Caspase-1, and NLRP3), and pyroptosis (GSDMD) in the hypothalamic paraventricular nucleus (PVN), which evoked massive inflammatory cytokine production (IL-1β, TNF-α, IL-18, and MCP-1) and oxidative stress responses (Cu/Zn-SOD activity, GSH-PX, and MDA) in the SHR group. Notably, anatabine not only prevented cardiac structural remodeling and attenuated sympathetic activation but also reduced the inflammatory reaction from the NF-κB activity, NLRP3-dependent inflammasome and pyroptosis, and decreased reactive oxygen species (ROS) overproduction in the PVN of hypertensive rats. In vitro, microglia stimulated inflammation after adding Ang II; oxidative stress responses were activated, while the inflammasome compounds and cytokines were overexpressed. The anatabine inhibited NF-κB activity, NLRP3/caspase-1-dependent pyroptosis and oxidative stress in Ang II-induced microglia. Conversely, those responses were aggravated after the NF-κB activator in HMC3. Chronic hypertension activates the NLRP3 inflammasome and pyroptosis-driven inflammatory responses, leading to oxidative stress in the PVN. Sustained administration of anatabine reached the PVN and suppressed the NF-κB/NLRP3/caspase-1-dependent pyroptosis pathway in microglia, reducing excessive ROS generation in the PVN, thereby effectively reducing sympathetic drive, attenuating blood pressure, and preventing cardiac structural remodeling in the process of hypertension. These findings suggest anatabine as a promising therapeutic agent for managing hypertension-related chronic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisOxidative StressParaventricular Hypothalamic NucleusNF-kappa BCaspase 1HypertensionInflammasomesMicrogliaAlkaloidsAnti-Inflammatory AgentsBlood PressureAntihypertensive AgentsAnimalsRats, Inbred WKYMaleRats, Inbred SHRSignal TransductionDisease Models, AnimalInflammation Mediators

Stichwörter der Autor:innen

AnatabineCaspase-1HypertensionInflammationParaventricular nucleus

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratNF-kappa BCaspase 1InflammasomesAlkaloidsAnti-Inflammatory AgentsAntihypertensive AgentsInflammation Mediators

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an, 710061, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Institute of Advanced Clinical Medicine, Peking University, Beijing, 100191, China.
  • China Heart Hospital, Xi'an International Medical Center Hospital, Northwest University, Xi'an, 710161, China.
  • The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
  • Department of Clinical Medical, Xi'an Jiaotong University, Xi'an, 710061, China.

Förderung

  • Province Key Research and Development Program of Shaanxi
  • Fundamental Research Funds for the Central Universities
  • Shaan'xi Province Postdoctoral Science Foundation
  • Shaanxi Province Natural Science Basic Research Program
  • National Natural Science Foundation of China
  • Shaan’xi Province Postdoctoral Science Foundation

Zitieren

APA

Su, Q., Li, S. J., Zhou, J. Y., Yang, J. B., Zhao, F., Zou, G. Q., Ma, J. X., Liu, Q., Feng, Y. Y., Yang, C. L., Li, Y., Li, H. B., & Xu, M. L. (2025). Chronic Anatabine Administration Attenuates Cardiovascular Activity by Targeting NF-κB/NLRP3/Caspase-1-Dependent Pyroptosis and Oxidative Stress in Paraventricular Nucleus of Hypertensive Rat. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-025-10034-2

Vancouver

Su Q, Li SJ, Zhou JY, Yang JB, Zhao F, Zou GQ, et al. Chronic Anatabine Administration Attenuates Cardiovascular Activity by Targeting NF-κB/NLRP3/Caspase-1-Dependent Pyroptosis and Oxidative Stress in Paraventricular Nucleus of Hypertensive Rat. Cardiovascular Toxicology. 2025. doi:10.1007/s12012-025-10034-2

BibTeX
@article{Su2025,
  author = {Su, Qing and Li, Shao-Jun and Zhou, Jun-Yu and Yang, Jin-Bao and Zhao, Fang and Zou, Guo-Quan and Ma, Jia-Xuan and Liu, Qi and Feng, Yuan-Yuan and Yang, Cui-Ling and Li, Ying and Li, Hong-Bao and Xu, Meng-Lu},
  title = {Chronic Anatabine Administration Attenuates Cardiovascular Activity by Targeting NF-κB/NLRP3/Caspase-1-Dependent Pyroptosis and Oxidative Stress in Paraventricular Nucleus of Hypertensive Rat},
  journal = {Cardiovascular Toxicology},
  year = {2025},
  doi = {10.1007/s12012-025-10034-2}
}
Kostenlos starten →